Google taps MediaTek to build Triggerfish TPU, possibly at expense of Broadcom, Qualcomm: GF
Google has reportedly chosen MediaTek to develop its TPUv9, codenamed Triggerfish, a move that could bypass traditional partners like Broadcom and Qualcomm. According to GF Securities, this decision suggests Google is looking for new collaborators in its AI chip development. This partnership highlights MediaTek's growing influence in the AI hardware sector.
Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness
The FDA has selected seven companies, including Eli Lilly and Regeneron, for its PreCheck Pilot Program. This initiative aims to accelerate the readiness of new U.S. pharmaceutical manufacturing facilities, thereby strengthening the domestic drug supply chain and improving access to critical medicines. The program offers a two-phase model providing technical guidance and earlier regulatory engagement to streamline the approval process for new production sites.
Dow Inc. Stock 12‑Month Price Target Cut to $41.76, Implies 50% Upside
Analysts have cut the average 12-month price target for Dow Inc. (DOW) stock to $41.76 from $42.12, implying approximately 50% potential upside based on the June 29 closing price. Despite the reduction, the consensus rating from 23 analysts remains "Buy," with a breakdown of 11 Buys, 10 Holds, and 2 Sells.
Coca-Cola Consolidated tops 250,000 meals for America250 drive
Coca-Cola Consolidated (NASDAQ:COKE) announced it has surpassed its goal of providing 250,000 meals in celebration of America's 250th anniversary, ultimately packing nearly 300,000 meals. The initiative, aimed at addressing food insecurity, involved partnerships with nonprofits, sports teams, and retailers across 14 states and Washington, D.C. The company emphasized its commitment to community service and the power of partnerships to support families in need.
FDA selects seven companies including Eli Lilly and Regeneron for accelerated manufacturing review pilot
The U.S. FDA has chosen seven companies, including Eli Lilly and Regeneron Pharmaceuticals, for its PreCheck Pilot Program. This initiative aims to accelerate the review process for new domestic pharmaceutical manufacturing facilities by allowing regulators to assess sites during construction, potentially saving companies up to 14 months in approval time. The selected facilities will produce a variety of products, such as GLP-1 ingredients, biologics, and gene therapies, to address drug supply gaps and expand patient access in areas of unmet medical need.
Price to sales forward of National Bankshares, Inc. – NASDAQ:NKSH
This article provides "Price to sales forward" data for National Bankshares, Inc. (NASDAQ: NKSH). It appears to be a financial data point from TradingView, indicating a specific valuation metric for the company. The content itself does not offer detailed analysis but rather presents a data field for the mentioned period.
MSFT Investors Have Opportunity to Lead Microsoft Corporation Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is reminding Microsoft (NASDAQ: MSFT) investors of a class action lawsuit against the company for alleged securities fraud. The lawsuit claims Microsoft made false statements regarding its Copilot AI products, citing poor user experience, capacity limitations, and underperformance against competitors. Investors who purchased Microsoft securities between May 1, 2025, and January 28, 2026, are encouraged to contact the firm to participate before August 11, 2026.
1 Core Catalyst Makes U.S. Bancorp a Premier Safe Haven for Retirees Protecting Their Future
U.S. Bancorp (NYSE:USB) is presented as a strong dividend stock for retirees, having paid uninterrupted dividends for over 160 years. The article highlights its healthy 45% earnings payout ratio and robust 10.8% CET1 capital ratio, offering multiple layers of dividend protection. Although the quarterly payout has held flat recently due to a pending acquisition, management is committed to strategic priorities and sustainable EPS growth.
News | RTX's Pratt & Whitney F119 engine surpasses one million flight hours
Pratt & Whitney, an RTX business, announced that its F119 engine, which powers the F-22 Raptor, has exceeded one million flight hours. This milestone highlights the engine's critical role in U.S. Air Force air dominance, offering superior performance, stealth, thrust vectoring, and supercruise capabilities for over two decades. The F119 has also served as the technological foundation for the F135 engine in the F-35 Lightning II.
Enabling connected well, reservoir, and operations workflows with unified data
This case study details how an operator, facing challenges with inconsistent production data formats and a lack of a central analysis tool, implemented SLB's Avocet production operations software and OFM well and reservoir analysis software. The solution created a central data repository, streamlining data management, validation, and reporting, and significantly reducing the time required for data processing and quality control from days to hours. This unification improved efficiency, collaboration, and the speed and effectiveness of decisions related to production and field development.







